BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2009
View Archived Issues
Inotek reports results from phase I/II clinical trial of INO-8875 in glaucoma
Read More
Boehringer Ingelheim discloses CGRP antagonists for the treatment of migraine
Read More
Abbott describes novel vitamin D receptor activators for the treatment of bone disorders
Read More
LB-03002 significantly reduces fat mass in adults with growth hormone deficiency
Read More
Phase III data on 13-valent vaccine show coverage against pneumococcal disease
Read More
Secondary leukemias seen with ibritumomab in indolent/aggressive lymphoma patients
Read More
Small study suggests donepezil can improve sleep apnea
Read More
Antisense Therapeutics completes CSR for phase IIa clinical trial of ATL/TV1102 in MS
Read More
Sorafenib beneficial in phase II differentiated thyroid carcinoma trial
Read More
Evotec completes phase I study of EVT-401 in healthy male volunteers
Read More
FEVER trial analysis shows reduced cardiovascular event risk in lower-risk patients with felodipine
Read More
Ardea Biosciences' MEK inhibitors show efficacy in arthritis model
Read More
Takeda submits additional indication and NDA applications for alogliptin
Read More
Achillion starts dosing in first-in-human ACH-1625 trial for hepatitis C
Read More
Innate reports phase IIa results for IPH-1101 in hepatitis C virus infection
Read More
CSL to commence trial of novel H1N1 swine flu candidate vaccine
Read More
Biolex completes enrollment in SELECT-2 phase IIb Locteron trial in HCV
Read More
AcelRx presents phase II results from ARX-01 Sufentanil NanoTabs trial in pain
Read More
Cephalon submits Nuvigil sNDA for sleepiness associated with jet lag disorder
Read More
Pozen submits NDA for PN-400 in collaboration with AstraZeneca
Read More
Ablynx advances ALX-0061 into preclinical development for autoimmune diseases
Read More
Novartis initiates phase III clinical study of NVA-237 in COPD
Read More
AlphaRx and Gaia report preclinical results from studies of GAI-122 for postoperative delirium
Read More
Vantia reports results from phase IIa clinical trial of VA-106483 in nocturia
Read More
Palkion initiates preclinical development of anemia drug that modulates HIF-PH
Read More
FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease
Read More
